S100B blood level measurement to exclude cerebral lesions after minor head injury: The multicenter STIC-S100 French study

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 4, 2014, Pages 527-536

  Laribi, Said ^a   Kansao, Jamal ^b   Borderie, Didier ^b   Collet, Corinne ^a   Deschamps, Patrick ^c   Ababsa, Redha ^c   Mouniam, Léonard ^d   Got, Laurence ^d   Leon, Alain ^e   Thoannes, Henri ^e   Santin, Aline ^f   Kouyoumdjian, Jean Claude ^f   Dahyot Fizelier, Claire ^g   Millet, Catherine ^g   Golmard, Jean Louis ^h   Beaudeux, Jean Louis ⁱ  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Institut Cochin   (France)

^c Pontoise Hospital   (France)

^d Medical Oncology   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

biomarker; cranial computed tomography; liquid phase immunoassay; minor head injury; S100B protein

Indexed keywords

PROTEIN S100B; S100B PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOMATION; BRAIN DAMAGE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEAD INJURY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; BRAIN INJURIES; BRAIN ISCHEMIA; CLINICAL TRIAL; DRINKING BEHAVIOR; FRANCE; PROSPECTIVE STUDY; REPRODUCIBILITY; YOUNG ADULT;

ADULT; ALCOHOL DRINKING; AUTOMATION; BRAIN INJURIES; BRAIN ISCHEMIA; FRANCE; HUMANS; IMMUNOASSAY; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84896762135     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0621     Document Type: Article

References (38)

1. Cassidy JD, Carroll LJ, Peloso PM, Borg J, von Holst H, Holm L, et al. Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO collaborating centre task force on mild traumatic brain injury. J Rehabil Med 2004;43: 28-60. (Pubitemid 38268223)
2. Smith-Bindman R. Is computed tomography safe? N Engl J Med 2010;363:1-4.
3. Haydel MJ, Preston CA, Mills TJ, Luber S, Blaudeau E, DeBlieux PM. Indications for computed tomography in patients with minor head injury. N Engl J Med 2000;343:100-5. (Pubitemid 30451853)
4. Nash DL, Bellolio MF, Stead LG. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit Care 2008;8:301-7.
5. Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78:1428-33.
6. Cervellin G, Benatti M, Carbucicchio A, Mattei L, Cerasti D, Aloe R, et al. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clin Biochem 2012;45:408-11.
7. Tavarez MM, Atabaki SM, Teach SJ. Acute evaluation of pedriatric patients with minor traumatic brain injury. Curr Opin Pediatr 2012;24:307-13.
8. Egea-Guerrero JJ, Revuelto-Rey J, Murillo-Cabezas F, Munoz-Sanchez MA, Vilches-Arenas A, Sanchez-Linares P, et al. Accuracy of the S100B protein as a marker of brain damage in traumatic brain injury. Brain Inj 2012;26:76-82.
9. Unden J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis. J Head Trauma Rehabil 2010;25:228-40.
10. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F. Rapid elimination of protein S100B from serum after minor head injury. J Neurotrauma 2006;23:149-55.
11. Jonsson H, Johnsson P, Hoglund P, Alling C, Blomquist S. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:698-701.
12. Morochovic R, Racz O, Kitka M, Pingorova S, Cibur P, Tomkova D, et al. Serum S100B protein in early management of patients after mild traumatic brain injury. Eur J Neurol 2009;16:1112-7.
13. Bouvier D, Oddoze C, Ben Haim D, Moustafa F, Legrand A, Alazia M, et al. Interest of S100B protein blood level determination for the management of patients with minor head traum. Ann Biol Clin (Paris) 2009;67:425-31.
14. Poli-de-Figueiredo LF, Biberthaler P, Simao Filho C, Hauser C, Mutschler W, Jochum M. Measurement of S-100B for risk classification of vitims sustaining minor head injury-First pilot study in Brazil. Clinics (Sao Paulo) 2006;61:41-6. (Pubitemid 43578795)
15. Bazarian JJ, Beck C, Blyth B, von Ahsen N, Hasselblatt M. Impact of creatine kinase correction on the predictive value of S100B after mild traumatic brain injury. Restor Neurol Neurosci 2006;24:163-72. (Pubitemid 44081717)
16. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, et al. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: a propsective multicentre study. Shock 2006;25:446-53.
17. Nygren de Boussard C, Fredman P, Lundin A, Andersson K, Edman G, Borg J. S100 in mild traumatic brain injury. Brain Inj 2004;18:671-83. (Pubitemid 38735473)
18. Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock 2002;18:395-400.
19. Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Mutschler W, Linsenmaier U, et al. Rapid identification of high-risk patients after minor head traum (MHT) by assessment of S-100B: ascertainement of a cut-off level. Eur Med Res J 2002;7: 164-70.
20. Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, et al. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World J Surg 2001;25:93-7. (Pubitemid 32422226)
21. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000;14:1047-55. (Pubitemid 32013963)
22. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavorial outcome. Neurosurgery 1999;45:468-75.
23. Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, et al. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 2012;59: 209-18.
24. Bouvier D, Fournier M, Dauphin JB, Amat F, Ughetto S, Labbé A, et al. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clin Chem 2012;58: 1116-22.
25. Oh EJ, Kim YM, Jegal DW, Kahng J, Park YJ, Han K. Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department. J Clin Lab Anal 2007;21:387-92. (Pubitemid 350250407)
26. Pickering A, Carter J, Hanning I, Townend W. Emergency department measurement of urinary S100B in children following head injury: can extracranial injury confound findings? Emerg Med J 2008;25:88-9. (Pubitemid 351193834)
27. Unden J, Bellner J, Eneroth M, Alling C, Ingebrigtsen T, Romner B. Raised serum S100B levels after acute bone fractures without cerebral injury. J Trauma 2005;58:59-61. (Pubitemid 40221734)
28. Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, et al. Extracranial sources so S100B do not affect serum levels. Plos One 2010;5:e12691.
29. Sloan EP, Zalenski RJ, Smith RF, Sheaff CM, Chen EH, Keys NI, et al. Toxicology screening in urban trauma patients: drug prevalence and its relationship to trauma severity and management. J Trauma 1989;29:1647-53. (Pubitemid 20024872)
30. Lange RT, Iverson GL, Brubacher JR. Clinical utility of the protein S100B to evaluate traumatic brain injury in the presence of acute alcohol intoxication. J Head Trauma Rehabil 2012;27:123-34.
31. Enochsson L, Carlsson-Sanz S, van der Linden J. The influence of alcohol and time on the S-100B levels of patients with minor head injury. Eur J Neurol 2005;12:445-8. (Pubitemid 40768663)
32. Einav S, Itshayek E, Kark JD, Ovadia H, Weiniger CF, Shoshan Y. Serum S100B levels after meningioma surgery: a comparison of two laboratory assays. BMC Clin Pathol 2008;19:8-9.
33. Muller K, Elverland A, Romner B, Waterloo K, Langbakk B, Undén J, et al. Analysis of protein S100B in serum: a methodological study. Clin Chem Lab Med 2006;44:1111-4. (Pubitemid 44370932)
34. Erickson JA, Grenache DG. Comparison of three assays for quantifying S100B in serum. Clin Chim Acta 2011;412:2122-7.
35. Calcagnile O, Unden L, Unden J. Clinical validation of S100B use in management of mild head injury. BMC Emerg Med 2012;12:13.
36. Bloomfield SM, McKinney J, Smith L, Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 2007;6:121-38. (Pubitemid 46934023)
37. Nylén K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir 2008;150:221-7.
38. Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, et al. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J Trauma 2011;71:S478-86.